EDGAR Filing Documents for 0001193125-18-175422

Form 8-K - Current report:

SEC Accession No. 0001193125-18-175422

Filing Date

2018-05-25

Accepted

2018-05-25 16:43:03

Documents

Period of Report

2018-05-24

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d567736d8k.htm	8-K	18114
2	EX-1.1	d567736dex11.htm	EX-1.1	195218
3	EX-5.1	d567736dex51.htm	EX-5.1	7123
4	GRAPHIC	g567736g0525065308362.jpg	GRAPHIC	2528
	Complete submission text file	0001193125-18-175422.txt		225284

Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306

Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845

Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 18862127
SIC: 2836 Biological Products, (No Diagnostic Substances)